1 entry found
1
Journal article icon

Journal article

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study

  • Coates, LC, Gladman, DD, Nash, P, et al.
  • 2018-12-07
FILTER RESULTS

TO TOP